|
|
 Previous Article | Table of Contents | Next Article 
RAPID COMMUNICATION
Bone Marrow Stroma-Derived Prolactin Is Involved in Basal and Platelet-Activating Factor-Stimulated In Vitro Erythropoiesis
Graziella Bellone,
Paola Astarita,
Elisa Artusio,
Stefania Silvestri,
Katia Mareschi,
Anna Turletti,
Stefano Buttiglieri,
Giorgio Emanuelli, and
Lina Matera
From the Departments of Clinical Physiopathology and Internal Medicine, University of Turin, Turin, Italy.
Cooperation between in vitro exogenous prolactin (PRL), granulocyte-macrophage colony-stimulating factor (GM-CSF), and interleukin-3 (IL-3) at an early step of in vitro erythroid differentiation has been shown in a previous study. To gain more insight into the role of PRL in in vivo hematopoiesis, we have now addressed the involvement of endogenous PRL in the growth of hematopoietic progenitors in a bone marrow (BM) stroma environment. The possible modulation of local PRL production by the inflammatory mediator platelet-activating factor (PAF), which is known to be produced by BM cells and to regulate pituitary PRL release, has also been evaluated. Development of burst-forming unit-erythroid (BFU-E) colonies from CD34+ hematopoietic progenitors cultured on a BM stroma cells (BMSC) layer was slightly, but significantly, reduced in the presence of an antihuman PRL antibody. Pretreatment of BMSC with PAF increased the BFU-E colony efficiency of cocultured CD34+ cells, and this effect was completely abrogated by the antiserum. PAF-modulated release of PRL by BMSC was confirmed by an enzyme-linked-immunospot (Elispot) technique. In addition, immunoprecipitation and Western blotting experiments showed two immunoreactive products in the BMSC culture medium. These corresponded to the nonglycosylated (23 kD) and glycosylated (25.5 kD) forms of pituitary PRL that are also expressed by the B-lymphoblastoid cell line IM9-P3. Specific increase of the nonglycosylated form and decrease of the glycosylated form was observed after PAF treatment. Polymerase chain reaction (PCR) amplification of reverse transcribed RNA using PRL-specific primers showed the presence of PRL message in BMSC and IM9-P3 cells. In situ hybridization experiments with a rat PRL cDNA probe cross-reacting with human PRL mRNA confirmed its presence in a small fraction of unstimulated BMSC and in the majority of PAF-stimulated BMSC. The enhancing effect of PAF on PRL-mediated colony formation, PRL release, and mRNA activation was counteracted by pretreating BMSC with the PAF-receptor (R) antagonist WEB 2170. Lastly, responsiveness of BMSC to PAF was substantiated by the presence of the PAF-R mRNA on these cells.
Blood, Vol. 90 No. 1 (July 1), 1997:
pp. 21-27
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J. M. Foulks, G. K. Marathe, N. Michetti, D. M. Stafforini, G. A. Zimmerman, T. M. McIntyre, and A. S. Weyrich
PAF-acetylhydrolase expressed during megakaryocyte differentiation inactivates PAF-like lipids
Blood,
June 25, 2009;
113(26):
6699 - 6706.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Abkowitz, G. Schaison, F. Boulad, D. L. Brown, G. R. Buchanan, C. A. Johnson, J. C. Murray, and K. M. Sabo
Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis
Blood,
September 26, 2002;
100(8):
2687 - 2690.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D W Montgomery
Prolactin production by immune cells
Lupus,
October 1, 2001;
10(10):
665 - 675.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L. Welniak, S. Richards, and W. Murphy
Effects of prolactin on hematopoiesis
Lupus,
October 1, 2001;
10(10):
700 - 705.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L Matera, M Mori, and A Galetto
Effect of prolactin on the antigen presenting function of monocyte-derived dendritic cells
Lupus,
October 1, 2001;
10(10):
728 - 734.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P. L. Greenberg, V. Gordeuk, S. Issaragrisil, N. Siritanaratkul, S. Fucharoen, and R. C. Ribeiro
Major Hematologic Diseases in the Developing World-- New Aspects of Diagnosis and Management of Thalassemia, Malarial Anemia, and Acute Leukemia
Hematology,
January 1, 2001;
2001(1):
479 - 498.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Bellone, C. Smirne, A. Carbone, K. Mareschi, L. Dughera, E. C. Farina, O. Alabiso, G. Valente, G. Emanuelli, and U. Rodeck
Production and Pro-Apoptotic Activity of Soluble CD95 Ligand in Pancreatic Carcinoma
Clin. Cancer Res.,
June 1, 2000;
6(6):
2448 - 2455.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
G. Bellone, C. Rollino, S. Borsa, I. Ferrero, G. Martina, A. Carbone, K. Mareschi, F. Quarello, G. Piccoli, G. Emanuelli, et al.
Association Between Elevated Prolactin Levels and Circulating Erythroid Precursors in Dialyzed Patients
Experimental Biology and Medicine,
April 1, 2000;
223(4):
367 - 371.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
